Aurobindo Pharma Limited (AUROPHARMA.NS)
INR 1266.0
(1.48%)
INR 1266.0
(1.48%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 54.16 INR | 64.62% |
| 2022 | 32.90 INR | -27.21% |
| 2021 | 45.20 INR | -50.36% |
| 2020 | 91.05 INR | 87.5% |
| 2019 | 48.56 INR | 20.32% |
| 2018 | 40.36 INR | -2.42% |
| 2017 | 41.36 INR | 5.16% |
| 2016 | 39.33 INR | 13.44% |
| 2015 | 34.67 INR | 28.26% |
| 2014 | 27.03 INR | 34.21% |
| 2013 | 20.14 INR | 298.81% |
| 2012 | 5.05 INR | 338.21% |
| 2011 | -2.12 INR | -121.65% |
| 2010 | 9.79 INR | -5.96% |
| 2009 | 10.41 INR | 456.68% |
| 2008 | 1.87 INR | -57.98% |
| 2007 | 4.45 INR | 18.04% |
| 2006 | 3.77 INR | 183.46% |
| 2005 | 1.33 INR | 1978.13% |
| 2004 | 0.06 INR | -97.18% |
| 2003 | 2.27 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 15.69 INR | 1.16% |
| 2023 Q2 | 12.92 INR | 32.65% |
| 2023 Q3 | 15.98 INR | 23.68% |
| 2023 Q4 | 15.51 INR | -2.94% |
| 2023 FY | - INR | 64.62% |
| 2023 Q1 | 9.74 INR | 12.73% |
| 2022 FY | - INR | -27.21% |
| 2022 Q2 | 6.99 INR | -21.28% |
| 2022 Q1 | 8.88 INR | -9.76% |
| 2022 Q3 | 8.38 INR | 19.89% |
| 2022 Q4 | 8.64 INR | 3.1% |
| 2021 Q2 | 11.89 INR | -9.51% |
| 2021 Q3 | 10.32 INR | -13.2% |
| 2021 Q4 | 9.84 INR | -4.65% |
| 2021 Q1 | 13.14 INR | -3.95% |
| 2021 FY | - INR | -50.36% |
| 2020 Q2 | 13.78 INR | 3.45% |
| 2020 Q3 | 50.31 INR | 265.09% |
| 2020 FY | - INR | 87.5% |
| 2020 Q4 | 13.68 INR | -72.81% |
| 2020 Q1 | 13.32 INR | -8.14% |
| 2019 Q1 | 10.85 INR | 8.61% |
| 2019 FY | - INR | 20.32% |
| 2019 Q4 | 14.50 INR | 20.43% |
| 2019 Q3 | 12.04 INR | 10.26% |
| 2019 Q2 | 10.92 INR | 0.65% |
| 2018 Q1 | 7.78 INR | -13.75% |
| 2018 FY | - INR | -2.42% |
| 2018 Q4 | 9.99 INR | -17.78% |
| 2018 Q3 | 12.15 INR | 16.38% |
| 2018 Q2 | 10.44 INR | 34.19% |
| 2017 Q1 | 8.85 INR | -2.75% |
| 2017 FY | - INR | 5.16% |
| 2017 Q4 | 9.02 INR | -11.22% |
| 2017 Q3 | 10.16 INR | -23.78% |
| 2017 Q2 | 13.33 INR | 50.62% |
| 2016 Q3 | 9.88 INR | -5.09% |
| 2016 FY | - INR | 13.44% |
| 2016 Q2 | 10.41 INR | 4.2% |
| 2016 Q1 | 9.99 INR | 5.27% |
| 2016 Q4 | 9.10 INR | -7.89% |
| 2015 Q2 | 7.77 INR | -3.96% |
| 2015 Q4 | 9.49 INR | 1.82% |
| 2015 Q3 | 9.32 INR | 19.95% |
| 2015 Q1 | 8.09 INR | 17.42% |
| 2015 FY | - INR | 28.26% |
| 2014 Q1 | 7.13 INR | -16.71% |
| 2014 FY | - INR | 34.21% |
| 2014 Q4 | 6.89 INR | 4.39% |
| 2014 Q3 | 6.60 INR | 3.29% |
| 2014 Q2 | 6.39 INR | -10.38% |
| 2013 FY | - INR | 298.81% |
| 2013 Q4 | 8.56 INR | 19.39% |
| 2013 Q1 | 0.32 INR | -82.7% |
| 2013 Q2 | 4.04 INR | 1162.5% |
| 2013 Q3 | 7.17 INR | 77.48% |
| 2012 FY | - INR | 338.21% |
| 2012 Q4 | 1.85 INR | 17.09% |
| 2012 Q3 | 1.58 INR | -58.64% |
| 2012 Q1 | -2.21 INR | -220.11% |
| 2012 Q2 | 3.82 INR | 272.85% |
| 2011 Q3 | -0.49 INR | 0.0% |
| 2011 Q4 | 1.84 INR | 475.51% |
| 2011 FY | - INR | -121.65% |
| 2010 FY | - INR | -5.96% |
| 2009 FY | - INR | 456.68% |
| 2008 FY | - INR | -57.98% |
| 2007 FY | - INR | 18.04% |
| 2006 FY | - INR | 183.46% |
| 2005 FY | - INR | 1978.13% |
| 2004 FY | - INR | -97.18% |
| 2003 FY | - INR | 0.0% |